These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 39289658)

  • 1. Neuroblastoma with high ASPM reveals pronounced heterogeneity and poor prognosis.
    Li C; Lu X; Zhang F; Huang S; Ding L; Wang H; Chen S
    BMC Cancer; 2024 Sep; 24(1):1151. PubMed ID: 39289658
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Whole-tumoral metabolic heterogeneity in
    Liu J; Ren Q; Xiao H; Li S; Zheng L; Yang X; Feng L; Zhou Z; Wang H; Yang J; Wang W
    Cancer Imaging; 2024 Jun; 24(1):72. PubMed ID: 38863073
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Value of pretreatment 18F-FDG PET/CT in prognosis and the reflection of tumor burden: a study in pediatric patients with newly diagnosed neuroblastoma.
    Man S; Yan J; Li J; Cao Y; Hu J; Ma W; Liu J; Zhao Q
    Int J Med Sci; 2021; 18(8):1857-1865. PubMed ID: 33746603
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic Values of Primary Tumor Textural Heterogeneity and Blood Biomarkers in High-risk Neuroblastoma.
    Vural O; Aydos U; Okur A; Pinarli FG; Atay LÖ
    J Pediatr Hematol Oncol; 2023 Oct; 45(7):383-391. PubMed ID: 37027243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of metabolic indices and bone marrow uptake pattern on preoperative 18F-FDG PET/CT in pediatric patients with neuroblastoma.
    Li C; Zhang J; Chen S; Huang S; Wu S; Zhang L; Zhang F; Wang H
    Eur J Nucl Med Mol Imaging; 2018 Feb; 45(2):306-315. PubMed ID: 29110068
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic value of
    Liu J; Si Y; Zhou Z; Yang X; Li C; Qian L; Feng LJ; Zhang M; Zhang SX; Liu J; Kan Y; Gong J; Yang J
    Cancer Imaging; 2022 Jul; 22(1):32. PubMed ID: 35791003
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic Value of Metabolic Parameters and Textural Features in Pretreatment
    Wang G; Si Y; Liu J; Wang W; Yang J
    Acad Radiol; 2024 Mar; 31(3):1091-1101. PubMed ID: 37748956
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of urokinase plasminogen activator and its receptor in metastasis and invasion of neuroblastoma.
    Li P; Gao Y; Ji Z; Zhang X; Xu Q; Li G; Guo Z; Zheng B; Guo X
    J Pediatr Surg; 2004 Oct; 39(10):1512-9. PubMed ID: 15486896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Clinical characteristics and prognosis of high-risk neuroblastoma with bone marrow metastasis in children].
    Fan HJ; Huang C; Su Y; Wang XD; Zhou YC; Duan C; Zhao W; Zhao Q; Jin M; Ma XL
    Zhonghua Er Ke Za Zhi; 2019 Nov; 57(11):863-869. PubMed ID: 31665841
    [No Abstract]   [Full Text] [Related]  

  • 10. Metabolomic profiling in neuroblastoma.
    Quintás G; Yáñez Y; Gargallo P; Juan Ribelles A; Cañete A; Castel V; Segura V
    Pediatr Blood Cancer; 2020 Mar; 67(3):e28113. PubMed ID: 31802629
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic value of pretreatment FDG PET in pediatric neuroblastoma.
    Lee JW; Cho A; Yun M; Lee JD; Lyu CJ; Kang WJ
    Eur J Radiol; 2015 Dec; 84(12):2633-9. PubMed ID: 26462795
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic significance of pretreatment
    Sung AJ; Weiss BD; Sharp SE; Zhang B; Trout AT
    Pediatr Radiol; 2021 Jul; 51(8):1400-1405. PubMed ID: 33629142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of Five Neuroblastoma Genes in Bone Marrow or Blood of Patients with Relapsed/Refractory Neuroblastoma Provides a New Biomarker for Disease and Prognosis.
    Marachelian A; Villablanca JG; Liu CW; Liu B; Goodarzian F; Lai HA; Shimada H; Tran HC; Parra JA; Gallego R; Bedrossian N; Young S; Czarnecki S; Kennedy R; Weiss BD; Goldsmith K; Granger M; Matthay KK; Groshen S; Asgharzadeh S; Sposto R; Seeger RC
    Clin Cancer Res; 2017 Sep; 23(18):5374-5383. PubMed ID: 28559462
    [No Abstract]   [Full Text] [Related]  

  • 14. Overexpression of the ASPM gene is associated with aggressiveness and poor outcome in bladder cancer.
    Xu Z; Zhang Q; Luh F; Jin B; Liu X
    Oncol Lett; 2019 Feb; 17(2):1865-1876. PubMed ID: 30675249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A nomogram for predicting recurrence-free survival of intermediate and high-risk neuroblastoma.
    Sun Q; Chen Y; Jin Q; Yuan X
    Eur J Pediatr; 2022 Dec; 181(12):4135-4147. PubMed ID: 36149505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The prognostic strength of serum LDH and serum ferritin in children with neuroblastoma: A report from the International Neuroblastoma Risk Group (INRG) project.
    Moroz V; Machin D; Hero B; Ladenstein R; Berthold F; Kao P; Obeng Y; Pearson ADJ; Cohn SL; London WB
    Pediatr Blood Cancer; 2020 Aug; 67(8):e28359. PubMed ID: 32472746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predicting event-free survival after induction of remission in high-risk pediatric neuroblastoma: combining
    Feng L; Yang X; Wang C; Zhang H; Wang W; Yang J
    Pediatr Radiol; 2024 May; 54(5):805-819. PubMed ID: 38492045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of YAP-1, OTX-2, and nestin protein expressions in neuroblastoma: a preliminary study.
    Kum Özşengezer S; Altun ZS; Sanlav G; Baran B; Kızmazoğlu D; Aktaş S; Keskinoğlu P; Olgun N
    Ann Clin Transl Neurol; 2024 Aug; 11(8):2153-2165. PubMed ID: 38925618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of fluorodeoxyglucose positron emission tomography derived metabolic parameters and textural features in pediatric sarcoma.
    Aydos U; Sever T; Vural Ö; Topuz Türkcan B; Okur A; Akdemir ÜÖ; Poyraz A; Pinarli FG; Atay LÖ; Karadeniz C
    Nucl Med Commun; 2022 Jul; 43(7):778-786. PubMed ID: 35506271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A nomogram of clinical and biologic factors to predict survival in children newly diagnosed with high-risk neuroblastoma: An International Neuroblastoma Risk Group project.
    Moreno L; Guo D; Irwin MS; Berthold F; Hogarty M; Kamijo T; Morgenstern D; Pasqualini C; Ash S; Potschger U; Ladenstein R; Valteau-Couanet D; Cohn SL; Pearson ADJ; London WB
    Pediatr Blood Cancer; 2021 Mar; 68(3):e28794. PubMed ID: 33205902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.